BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AIBioTech Establishes Assay Platform for Detection of Synthetic Cannabinoids, Stimulants, and PDE5 Inhibitors


8/21/2012 9:41:02 AM

RICHMOND, Va.--(BUSINESS WIRE)--The recently enacted Synthetic Drug Abuse Prevention Act of 2012 placed “cannabimimetic agents” and certain classes of amphetamine-like stimulants into the Controlled Substance Act. These compounds were placed into the CSA because they present an “imminent hazard to the public safety.” As a result of this act and numerous individual State legislations, possession with the intent to distribute these “misbranded drugs or synthetic drug products” may be a felony, and subject to criminal, civil, or administrative penalties. And yet, sale of “herbal”, “bath salt”, and other products which contain these substances continues. Users across the nation have become seriously ill, suffering seizures and hallucinations. The chemicals are suspected in at least nine US deaths since last year, and according to the Associated Press, medical emergencies related to synthetic drugs could go up nearly five-fold by year’s end. Also of considerable concern, “male enhancement” products commonly sold in convenience stores and over the internet have now been found to contain extraordinarily high levels of PDE5 inhibitors, the same active ingredients as found in drugs prescribed for erectile dysfunction.

Read at BioSpace.com

AIBioTech
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES